Insulet Corporation (PODD) Q2 Revenue Surges 32.9% to $649M, Raises Full-Year Guidance
We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Insulet Corporation is one of them. Insulet Corporation (NASDAQ:PODD) is a global leader in tubeless insulin pump technology, offering innovative diabetes management solutions through its Omnipod Insulin Management System. The flagship Omnipod 5 Automated Insulin Delivery System integrates with continuous glucose monitors to deliver automated, needle-free insulin dosing for type 1 and type 2 diabetes patients, contro ...